Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

Details for Australian Patent Application No. 2003277162 (hide)

International Classifications

Event Publications

19 February 2004 Complete Application Filed

Priority application(s): 10/262,573 30.09.02 US; 60/480,253 20.06.03 US

20 May 2004 Application Open to Public Inspection

Published as AU-B-2003277162

16 July 2009 Application Accepted

Published as AU-B-2003277162

3 September 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 02 Jul 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2003295466 802.11using a compressed reassociation exchange to facilitate fast handoff Cisco Technology, Inc. The nature of the amendment is as shown in the statement(s) filed 06 Aug 2009. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000 2004

24 December 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 02 Jul 2009

7 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.